Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Atrium Medical Corp.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Atrium Medical Corp.

Regulatory records
4
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 4 FDA records to the applicant name Atrium Medical Corp.. 2 entries are PMA supplements. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Aug 20, 2025 to May 13, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code PRL appears in 4 of the 4 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P120003, with 4 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 5 Wentworth Dr., Hudson, NH, 03051. Recorded on P120003/S007, decision dated May 13, 2026.

Changes described in PMA records

P120003/S007: iCast Covered Stent System

FDA’s recorded scope: Approval for use of a new sterilization cycle with parametric release at the existing sterilizer

May 13, 2026 · 135 Review Track For 30-Day Notice

P120003/S009: iCast Covered Stent System

FDA’s recorded scope: approval to add new implant sizes to the design matrix (10mm x 59mm stent, 32mm stent length, and 12mm stent diameter)

Dec 22, 2025 · Normal 180 Day Track

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
Atrium Medical Corp.PMA supplementMay 13, 2026FDA
Atrium Medical Corp.PMA supplementDec 22, 2025FDA
Atrium Medical Corp.PMA supplementSep 12, 2025FDA
Atrium Medical Corp.PMA supplementAug 20, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.